HTC Clinical Director Presents at Sepsis Research Event
26 May 2017
Trauma HTC Clinical Director, Dr Tom Clutton-Brock, presented at the first of a regular series of Innovation Engine events in the Institute of Translational Medicine at the University Hospitals Birmingham NHS Foundation Trust.
The aim of the event series is to stimulate conversations and collaborations between clinicians, industry and researchers, which will lead to innovative solutions to the challenges within the NHS. The first event focused on the issue of sepsis and the challenges faced in detecting and treating it, as well rehabilitating those patients affected by it. Clinicians Dr Ron Daniels, Dr Tony Whitehouse and Dr Tom Clutton-Brock presented on the challenges they face within their discipline when treating sepsis. The presentations were followed by a discussion session and the opportunity to network with clinicians, academics and those from industry.
There are around 123,000 cases of sepsis a year in England, where around 37,000 people die every year as a result of the condition. The number of cases worldwide is unknown as there is little data from the developing world. Antibiotics are the most common method of treatment for sepsis but as rates of antibiotic resistant bacteria increase, new methods of treatment need to be developed to ensure that sepsis remains a treatable condition.